1984

In December, following Oxford statistician Richard Peto’s explanation of meta-analysis of six previous aspirin studies indicating aspirin improved odds against second heart attack death by between a fifth and a quarter, FDA allows Sterling Product’s change in aspirin labelling. Less than a year later, U.S. Health Secretary, Margaret Heckler, told media that one aspirin tab a day could prevent secondary heart attacks (Jeffreys, 256-257).